Conmed Hemostasis
Device General Surgery
General payments
$280,052
Research payments
$0
Through program year 2025, $280,052 in general payments and $0 in research payments were reported against Conmed Hemostasis (General Surgery).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $27,053 | 212 |
| 2024 | General | $40,375 | 225 |
| 2023 | General | $21,113 | 165 |
| 2022 | General | $92,737 | 166 |
| 2021 | General | $50,091 | 111 |
| 2020 | General | $24,387 | 71 |
| 2019 | General | $24,296 | 109 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 14 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 26 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,059 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.